Serina Therapeutics Inc

Serina Therapeutics Inc a biotechnology company develops drugs to treat neurological diseases and pain Its lead product candidate is SER 252 a POZ conjugate for the treatment of Parkinsons disease The company also develops SER 227 for longacting pain relief SER 214 to treat Parkinsons disease and SER 228 for the treatment of epilepsy In addition it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases Serina Therapeutics Inc was founded in 2006 and is based in Huntsville Alabama